Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Yi

Showing results (661-670 of 699) with videos related to

Pageof 70
Sort By:
Chest|April 11, 2022
Predicting Usual Interstitial Pneumonia Histopathology From Chest CT Imaging With Deep LearningAlex Bratt, James M Williams, Grace Liu, et al.
Human Pathology|July 9, 2022
A diagnostic approach to paratesticular lesions with tubulopapillary architecture: a series of 16 serous borderline tumors/low-grade serous carcinoma and 14 well-differentiated papillary mesothelial tumors and mesotheliomaRabia Zafar, Lacey J Schrader, John C Cheville, et al.
Neoplasia (New York, N.Y.)|June 9, 2021
The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53Joanna S Yi, Oscar Sias-Garcia, Nicole Nasholm, et al.
Medchemcomm|August 16, 2018
Discovery and hit-to-lead evaluation of piperazine amides as selective, state-dependent Na<sub>V</sub>1.7 inhibitorsBrian A Sparling, S Yi, J Able, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
EZH2-driven immune evasion defines high-risk pediatric AML with t(16;21) FUS::ERG gene fusionNathaniel J Buteyn, Connor G Burke, Vincent J Sartori, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 16, 2026
Lipidomic profiles associated with treatment related hepatotoxicity in children with acute lymphoblastic leukemiaEmily J Mason, Jeremy M Schraw, John P Woodhouse, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Characterization of Chemoresistant Cell Populations Improves Risk Stratification and Therapy Prediction in Pediatric AMLMohammad Javad NajafPanah, Alexandra M Stevens, Michael J Krueger, et al.
Biorxiv : the Preprint Server for Biology|September 22, 2025
CAMKV Kinase Signaling Is a Novel Therapeutic Avenue with Prognostic Relevance in NeuroblastomaYang Yu, Yanling Zhao, Zhongcheng Shi, et al.
Scientific Reports|August 17, 2021
Comparative analysis of machine learning approaches to classify tumor mutation burden in lung adenocarcinoma using histopathology imagesApaar Sadhwani, Huang-Wei Chang, Ali Behrooz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2022
Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621Maureen M O'Brien, Lingyun Ji, Nirali N Shah, et al.
Pageof 70

Showing results (661-670 of 699) with videos related to

Sort By:
Pageof 70
Chest|April 11, 2022
Predicting Usual Interstitial Pneumonia Histopathology From Chest CT Imaging With Deep LearningAlex Bratt, James M Williams, Grace Liu, et al.
Human Pathology|July 9, 2022
A diagnostic approach to paratesticular lesions with tubulopapillary architecture: a series of 16 serous borderline tumors/low-grade serous carcinoma and 14 well-differentiated papillary mesothelial tumors and mesotheliomaRabia Zafar, Lacey J Schrader, John C Cheville, et al.
Neoplasia (New York, N.Y.)|June 9, 2021
The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53Joanna S Yi, Oscar Sias-Garcia, Nicole Nasholm, et al.
Medchemcomm|August 16, 2018
Discovery and hit-to-lead evaluation of piperazine amides as selective, state-dependent Na<sub>V</sub>1.7 inhibitorsBrian A Sparling, S Yi, J Able, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
EZH2-driven immune evasion defines high-risk pediatric AML with t(16;21) FUS::ERG gene fusionNathaniel J Buteyn, Connor G Burke, Vincent J Sartori, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 16, 2026
Lipidomic profiles associated with treatment related hepatotoxicity in children with acute lymphoblastic leukemiaEmily J Mason, Jeremy M Schraw, John P Woodhouse, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Characterization of Chemoresistant Cell Populations Improves Risk Stratification and Therapy Prediction in Pediatric AMLMohammad Javad NajafPanah, Alexandra M Stevens, Michael J Krueger, et al.
Biorxiv : the Preprint Server for Biology|September 22, 2025
CAMKV Kinase Signaling Is a Novel Therapeutic Avenue with Prognostic Relevance in NeuroblastomaYang Yu, Yanling Zhao, Zhongcheng Shi, et al.
Scientific Reports|August 17, 2021
Comparative analysis of machine learning approaches to classify tumor mutation burden in lung adenocarcinoma using histopathology imagesApaar Sadhwani, Huang-Wei Chang, Ali Behrooz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2022
Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621Maureen M O'Brien, Lingyun Ji, Nirali N Shah, et al.
Pageof 70